What is a stock summary page? Click here for an overview.
Business Description
Easywell Biomedicals Inc
NAICS : 339999
SIC : 2834
ISIN : TW0001799005
Description
Easywell Biomedicals Inc is engaged in drug development, manufacturing, and sales of active pharmaceutical ingredients and over-the-counter drug products The company's segment include the Drug development segment and Other segments.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.83 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.79 | |||||
| Debt-to-EBITDA | 44.25 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.57 | |||||
| Beneish M-Score | -2.08 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 33.3 | |||||
| 3-Year EPS without NRI Growth Rate | 18.7 | |||||
| 3-Year FCF Growth Rate | -3 | |||||
| 3-Year Book Growth Rate | -7.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.03 | |||||
| 9-Day RSI | 37.35 | |||||
| 14-Day RSI | 38.94 | |||||
| 3-1 Month Momentum % | 21.27 | |||||
| 6-1 Month Momentum % | -31.37 | |||||
| 12-1 Month Momentum % | 13.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.93 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 1.1 | |||||
| Days Inventory | 216.88 | |||||
| Days Sales Outstanding | 32.75 | |||||
| Days Payable | 49.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | -3.45 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.4 | |||||
| Operating Margin % | -12.92 | |||||
| Net Margin % | -18.04 | |||||
| FCF Margin % | -31.79 | |||||
| ROE % | -13.7 | |||||
| ROA % | -7.03 | |||||
| ROIC % | -7.77 | |||||
| 3-Year ROIIC % | 65.14 | |||||
| ROC (Joel Greenblatt) % | -9.97 | |||||
| ROCE % | -5.77 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 13.32 | |||||
| PB Ratio | 9.83 | |||||
| Price-to-Tangible-Book | 12.13 | |||||
| EV-to-EBIT | -107 | |||||
| EV-to-EBITDA | 563.21 | |||||
| EV-to-Revenue | 13.29 | |||||
| EV-to-FCF | -42.73 | |||||
| Price-to-GF-Value | 0.92 | |||||
| Price-to-Median-PS-Value | 2.14 | |||||
| Price-to-Net-Current-Asset-Value | 223.08 | |||||
| Earnings Yield (Greenblatt) % | -0.93 | |||||
| FCF Yield % | -2.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Easywell Biomedicals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 540.438 | ||
| EPS (TTM) (NT$) | -0.811 | ||
| Beta | 1 | ||
| 3-Year Sharpe Ratio | 0.91 | ||
| 3-Year Sortino Ratio | 1.57 | ||
| Volatility % | 88.15 | ||
| 14-Day RSI | 38.94 | ||
| 14-Day ATR (NT$) | 3.202092 | ||
| 20-Day SMA (NT$) | 63.875 | ||
| 12-1 Month Momentum % | 13.84 | ||
| 52-Week Range (NT$) | 49.9 - 233 | ||
| Shares Outstanding (Mil) | 121.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Easywell Biomedicals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Easywell Biomedicals Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Easywell Biomedicals Inc Frequently Asked Questions
What is Easywell Biomedicals Inc(ROCO:1799)'s stock price today?
The current price of ROCO:1799 is NT$58.00. The 52 week high of ROCO:1799 is NT$233.00 and 52 week low is NT$49.90.
When is next earnings date of Easywell Biomedicals Inc(ROCO:1799)?
The next earnings date of Easywell Biomedicals Inc(ROCO:1799) is .
Does Easywell Biomedicals Inc(ROCO:1799) pay dividends? If so, how much?
Easywell Biomedicals Inc(ROCO:1799) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers